The aim of this flow cytometry study in acute megakaryoblastic 
posterior iliac crest. The first 2 ml marrow aspirate was used for cytopathological diagnosis. An additional 5 ml was aspirated for flow cytometry analysis. In four AML-M7 patients, where no bone marrow aspirates were obtained due to myeloIntroduction fibrosis, a sample of mononuclear cells from 50 ml of peripheral blood was analysed. From these samples light-density mononuclear cells (MNC) were isolated by centrifugation on Acute megakaryoblastic leukaemia was first described as an Lymphoprep (Nycomed, Oslo, Norway). The MNC were entity in 1931 1 and in 1985 included in the FAB classification resuspended at 4°C in a solution of 95% fetal calf serum and of acute myeloid leukaemia.
2 The prominent features are 5% dimethyl sulphoxide and frozen immediately to −80°C in abnormal megakaryoblasts in blood and bone marrow often aliquots containing 2 × 10 7 MNC/ml suspension. associated with significant myelofibrosis.
Recognition of the abnormal cells as megakaryoblasts often requires additional phenotypic studies, and in recent years,
Cell morphology, cytochemistry and immunological
flow cytometry has gained increased importance in the diagidentification nosis of acute leukaemias.
3,4 However, the complexity of surface antigen expression, the heterogeneity of blast cells, and Blood films, bone marrow biopsies and marrow aspirates were the lack of prognostic significance of subclassification of AML examined by routine light microscopy. Bone marrow celluhave limited the usefulness in practice. 5 larity and fibrosis were graded semiquantitatively from + to In most acute leukaemias the malignant transformation is +++ (+: slightly increased, ++: markedly increased, +++: maxibelieved to occur in haematopoietic 'sleepers' or inactive mally increased). multipotent stem or early progenitor cells with the capacity of Monoclonal antibodies against CD61 (Dakopatts, Copenlineage differentiation.
6 Therefore, it is the hypothesis of this hagen, Denmark) and neutrophil elastase (Dakopatts), and study that the phenotype of leukaemic progenitors or stem polyclonal antibodies against Factor 8 (Dakopatts) and myelocells has more specific features compared to the phenotype peroxidase (MPO) (Dakopatts) were applied on bone marrow of the total 'feeder' population of leukaemic cells.
biopsies and stained using three-stage immunoperoxidase To evaluate this hypothesis we have performed a retrospecmethods as previously described. tive analysis of CD34 + lineage-specific subset in patients with AML-M7 and compared the results with other AML FAB types.
Flow cytometry immunophenotyping
Single parameter flow cytometry on the entire leukaemic population:
After thawing, the cell suspension was adjusted to 1 × 10 7 MNC/ml and an aliquot of 50 l corresponding to 5 × 10 5 MNC was labeled with 50 l of fluor-times and resuspended in 500 l phosphate-buffered saline detected and gated ( Figure 1 , step 1) in the upper left quadrant according to earlier published recommendations and stan-(PBS) with NaN 3 0.05%. The applied monoclonal antibodies were directed against the following surface antigens: CD3, dards. 8 A live gate was set around the CD34 + population. The anti-CD34 monoclonal antibody labelled and double stained CD13, CD14, CD33, CD34, CD38, CD45, CD61, glycophorin A and HLA-DR. Anti-CD13 and anti-CD33 were obtained cell suspensions were then analysed in an aquisition gate (Figure 1, step 2. ). The double staining was performed with from Coulter (Hialeah, FL, USA), anti-CD61 and anti-glycophorin A from Dakopatts and all other monoclonal antibodies monoclonal antibodies directed against one of the following surface antigens: CD14, CD13, CD33, CD38, CD61, glycofrom Becton Dickinson (BD) (Mountain View, CA, USA). Mouse isotype IgG (BD) served as negative control. The diagphorin A and HLA-DR. Flow cytometry was performed acquiring 1000-2000 CD34 + events in list mode. The enumeration nostic immunophenotyping was performed by flow cytometry using a FACScan equipped with an argon laser (BD). Gating (Figure 1, step 3 ) of cells expressing both the CD34 and the additional antigen was calculated as a percentage of all anawas set with forward-(FSC) and 90°light-scatter (SSC) parameters to exclude erythrocytes, platelets and subcellular lysed CD34 + cells, taking into consideration the negative isotype controls. In six AML-M0 to AML-M6 patients double debris. A total of 5000 cells was acquired in list mode and the frequency of the cells expressing the marker in question staining of CD34 + subset could not be performed due to very small CD34 + numbers. In only one of the AML-M7 patients was calculated as a percentage of all cells analysed.
was the double staining impaired due to a low CD34 + number.
Double marking to identify and quantitate the lineage specific CD34
+ subset (Figures 1 and 2 ): A total of 50 000 events from a cell suspension labelled with the anti-CD34 monclonal Statistical evaluation antibody as described above were counted in the flow cytometer with the FSC parameter set to exclude erythrocytes, platelets and debris. On a dot plot diagram, FL2 expressed Statistical analysis was performed by a two-sample rank sum test (Mann-Whitney test). A value of P Ͻ 0.01 was con-CD34 staining on the y-axis and SSC or granulation on the xaxis. Using quadrant statistics the CD34 + subset could then be sidered significant.
